Header Logo

Connection

RACHEL SCHIFF to Endocrine Gland Neoplasms

Back to Details
This is a "connection" page, showing publications RACHEL SCHIFF has written about Endocrine Gland Neoplasms.
RACHEL SCHIFF
Connection Strength
0.201
Endocrine Gland Neoplasms
  1. NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer. Sci Rep. 2022 02 04; 12(1):1972.
    View in: PubMed
    Score: 0.201
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.